This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1998 Mar;77(5):683-93.

doi: 10.1038/bjc.1998.114.

Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target

A P Zbar¹, N R Lemoine, M Wadhwa, H Thomas, D Snary, W A Kmiot

Affiliations

PMID: 9514045
PMCID: PMC2149974
DOI: 10.1038/bjc.1998.114

Free PMC article

Review

Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target

A P Zbar et al. Br J Cancer. 1998 Mar.

Free PMC article

. 1998 Mar;77(5):683-93.

doi: 10.1038/bjc.1998.114.

Authors

A P Zbar¹, N R Lemoine, M Wadhwa, H Thomas, D Snary, W A Kmiot

Affiliation

¹ Academic Department of Colorectal Surgery, Hammersmith Hospital, London, UK.

PMID: 9514045
PMCID: PMC2149974
DOI: 10.1038/bjc.1998.114

No abstract available

PubMed Disclaimer

Similar articles

Immunization effect of monoclonal antibodies against tumor-associated antigens during cancer treatment.
Fagerberg J, Frödin JE, Ragnhammar P, Steinitz M, Wigzell H, Mellstedt H. Fagerberg J, et al. Ann N Y Acad Sci. 1993 Aug 12;690:337-9. doi: 10.1111/j.1749-6632.1993.tb44023.x. Ann N Y Acad Sci. 1993. PMID: 8368748 No abstract available.
Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.
Zbar AP, Thomas H, Wilkinson RW, Wadhwa M, Syrigos KN, Ross EL, Dilger P, Allen-Mersh TG, Kmiot WA, Epenetos AA, Snary D, Bodmer WF. Zbar AP, et al. Int J Colorectal Dis. 2005 Sep;20(5):403-14. doi: 10.1007/s00384-004-0726-x. Epub 2005 Apr 30. Int J Colorectal Dis. 2005. PMID: 15864608 Clinical Trial.
Modulation of cancer patients' immune responses by anti-idiotypic antibodies.
Herlyn D, Wettendorff M, Koprowski H. Herlyn D, et al. Int Rev Immunol. 1989;4(4):347-57. doi: 10.3109/08830188909044787. Int Rev Immunol. 1989. PMID: 2519932 Review.
The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines.
Arlen P, Tsang KY, Marshall JL, Chen A, Steinberg SM, Poole D, Hand PH, Schlom J, Hamilton JM. Arlen P, et al. Cancer Immunol Immunother. 2000 Dec;49(10):517-29. doi: 10.1007/s002620000145. Cancer Immunol Immunother. 2000. PMID: 11129322 Free PMC article.
Immunotherapy for colorectal cancer.
Foon KA. Foon KA. Curr Oncol Rep. 2001 Mar;3(2):116-26. doi: 10.1007/s11912-001-0010-y. Curr Oncol Rep. 2001. PMID: 11177743 Review.

See all similar articles

Cited by

Functional HLA-DR T cell epitopes of CEA identified in patients with colorectal carcinoma immunized with the recombinant protein CEA.
Ullenhag GJ, Fagerberg J, Strigård K, Frödin JE, Mellstedt H. Ullenhag GJ, et al. Cancer Immunol Immunother. 2004 Apr;53(4):331-7. doi: 10.1007/s00262-003-0441-4. Epub 2003 Nov 7. Cancer Immunol Immunother. 2004. PMID: 14605762 Free PMC article.

References

1. Science. 1985 Dec 6;230(4730):1171-3 - PubMed
1. Br J Surg. 1986 Jun;73(6):483-6 - PubMed
1. Hybridoma. 1986 Jul;5 Suppl 1:S59-64 - PubMed
1. J Neurooncol. 1986;4(1):55-64 - PubMed
1. J Immunol. 1986 Nov 1;137(9):3042-8 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information